ispace (9348) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
18 Aug, 2025Executive summary
Net sales for the first three quarters rose 8.9% year-over-year to ¥1,989 million, but operating loss widened to ¥6,434 million and net loss attributable to owners reached ¥7,365 million, reflecting heavy R&D and upfront investments.
The company is advancing lunar missions, with Mission 2 achieving four of ten milestones and Mission 3 contract value increasing to US$65 million, including new agreements with NASA and the Italian Space Agency.
The business operates in a single segment focused on lunar surface development.
Financial highlights
Operating loss increased to ¥6,434 million from ¥3,748 million year-over-year; net loss attributable to owners expanded to ¥7,365 million from ¥837 million.
Gross profit for the period was ¥368 million, down from ¥805 million in the prior year.
Comprehensive loss for the period was ¥8,393 million, compared to ¥575 million in the previous year.
Basic net loss per share was ¥78.20, compared to ¥10.35 in the same period last year.
Outlook and guidance
Full-year net sales forecast revised upward to ¥4,467 million (up 89.5% year-over-year), but operating loss expected to widen to ¥9,872 million and net loss to ¥10,774 million.
No dividends are planned for the fiscal year.
The company is implementing measures to address going concern risks, including R&D promotion, customer development, and flexible funding strategies.
Latest events from ispace
- Net sales up 37.9% YoY, but losses persist amid R&D costs; liquidity strengthened.9348
Q3 25/2610 Feb 2026 - Net sales up 63.5% YoY, major capital raised, but operating losses continue.9348
Q2 25/2614 Nov 2025 - Q1 FY2025 featured lower sales, ongoing losses, and major new financing for lunar development.9348
Q1 24/2518 Aug 2025 - Operating and net losses widened despite higher sales, with new funding secured for future missions.9348
Q2 24/2518 Aug 2025 - Net sales surged 101% year-over-year, but losses deepened as R&D and mission investments accelerated.9348
Q4 24/2518 Aug 2025 - Net sales rose 83.5% YoY, but losses deepened after a hard lunar landing; liquidity improved.9348
Q1 25/2618 Aug 2025